IRRAS Announces Extension of CE Mark for IRRAflow System until May 2024
· European Union regulatory approval in place for IRRAflow Control Unit, Tube Sets, and Single-use Catheters until May 2024 · Extension of CE Mark expiration date ensures commercial availability of IRRAflow system without interruption during the European Union’s transition to new MDR regulatory standardsStockholm, July 22, 2020 – IRRAS AB, a commercial stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced the extension of the CE Mark until May 2024 for all components of its IRRAflow system, including the IRRAflow